Fulcrum Therapeutics Inc
(NAS:FULC)
$
4.79
-0.05 (-1.03%)
Market Cap: 258.37 Mil
Enterprise Value: 12.97 Mil
PE Ratio: 0
PB Ratio: 1.00
GF Score: 50/100 Fulcrum Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2021 / 09:20PM GMT
Release Date Price:
$18.28
(-3.94%)
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst
© -
Hi, everyone, and welcome to the final session of the 2021 Crédit Suisse Healthcare Conference. We're excited to have Bryan Stuart, President and CEO; and Chris Morabito, Chief Medical Officer, with us from Fulcrum. If anyone in the audience does have questions, you can certainly send them to me via email, [email protected], and I'll be sure to get those asked on your behalf. But we've got a long list here. So why don't we just jump in?
Questions & Answers
Judah C. Frommer;dit Suisse AG
CrÃ;Research Division - Senior Analyst
© -
I thought we could start with a little bit of background on the FulcrumSeek platform, and how it differentiates your discovery process versus competitors?
Bryan E. Stuart
Fulcrum Therapeutics, Inc. - President, CEO & Director
Yes. And Judah, thank you. We appreciate the time. We appreciate everybody tuning in. So Fulcrum was started about 6
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot